Trials / Completed
CompletedNCT02796534
Prevalence of Obstructive Sleep Apnea Syndrome in Type 1 Diabetic Patients Treated With Insulin Pump (At1Home)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 825 (actual)
- Sponsor
- University Hospital, Grenoble · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Patients with type 1 diabetes have poorer glycemic control that could lead to macrovascular or neuropathic complications; in addition to an optimal treatment, prevention of diabetes complications requires to control associated risk factors, such as hypertension or dyslipidemia. Sleep apnea syndrome is a public health problem due to its high prevalence and marked morbidity and mortality, one increasingly interesting aspect is its relationship with metabolic disorders, specifically diabetes.Obstructive sleep apnea syndrome seems to be underestimated in this population. In this context, it appears to be important to estimate the prevalence of sleep respiratory diseases in patients with type 1 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Diagnosis of sleep apnea by oxymetry |
Timeline
- Start date
- 2016-07-28
- Primary completion
- 2018-07-28
- Completion
- 2023-03-27
- First posted
- 2016-06-10
- Last updated
- 2025-12-29
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02796534. Inclusion in this directory is not an endorsement.